Servier India Gets CDSCO Nod for Brain Cancer Drug

By By Rediff Money Desk, New Delhi
Dec 10, 2025 17:07
Servier India receives CDSCO approval for Vorasidenib (Voranigo), a brain cancer drug for Grade 2 IDH-mutant glioma patients.
New Delhi, Dec 10 (PTI) Drug firm Servier India on Wednesday said it has
received marketing approval from the national drug regulator for a brain cancer medication.

The company has received marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for Vorasidenib (Voranigo), for use in patients with Grade 2 IDH-mutant glioma, a statement said.

Servier India is a subsidiary of French pharmaceutical group Servier.

The burden of the rare IDH mutated Grade 2 Gliomas is estimated to be 4,500 patients per year in India, with most being young adults, it said.

For more than 20 years, patients with these cancers have lacked new and precision based therapeutic options, highlighting an unmet medical need, it added. PTI MSS


Source: PTI
Read More On:
cdscoservier indiabrain cancer drugvorasidenib (voranigo)grade 2 idh-mutant glioma
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.

You May Like To Read

MORE NEWS

ICICI Prudential AMC IPO Opens Friday

ICICI Prudential AMC raises Rs 3,022 Cr from anchor investors. IPO opens Dec 12. Price...

AWS Invests $7B in Telangana Data Center Expansion

AWS to invest USD 7 billion in Telangana for data center expansion over 14 years. Boost...

Cyber Attacks Surge Post Operation Sindoor

Cyber attacks on government networks surged 7x after Operation Sindoor. NICSI MD...

RBI Injects Liquidity via OMO Purchase

RBI injects Rs 50,000 crore liquidity through Open Market Operation (OMO) purchases of...

IndiGo Flight Disruptions: Captain Gopinath...

Captain Gopinath analyzes IndiGo flight disruptions, citing arrogance, poor planning,...

Leverage Edu: Dubai Study Surge from India

Leverage Edu reports a 40x surge in applications from India to study in Dubai. Dubai is...

RBI Cancels NBFC Registrations

RBI cancels registration of 4 NBFCs, 4 others surrender certificates. Action taken...

RBI Eases Cash Credit Restrictions

RBI relaxes restrictions on cash credit facilities after stakeholder feedback. Draft...

Indian Startup Funding & Investments News

Latest funding news: Neosapien raises USD 2 mn, Isprout borrows Rs 60 cr, Ekta World...

Rajasthan Progressing: CM Sharma on Development

CM Sharma highlights Rajasthan's rapid progress in tourism, IT, renewable energy,...

Read More »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2025 Rediff.com